Clinical Trial Update: MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 MOSAIC trial evaluated oxaliplatin with 5-FU/leucovorin as adjuvant therapy for colon cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Colonic Neoplasms | Phase 3 | Status: COMPLETED